12:00 AM
 | 
Nov 10, 2008
 |  BioCentury  |  Strategy

Totting up the milestones

Totting up the milestones

Milestone event Amount
Prochymal
Achieve statistically significant endpoints in Ph II or Ph III trial in ulcerative colitis (UC) $10M
EMEA approval in UC $20M
FDA approval in graft-versus-host disease...

Read the full 205 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >